Anew Labs, a Shanghai, China-based artificial intelligence biotechnology and drug discovery startup, raised USD290m in funding at a USD1.5 billion valuation. The round was co-led by HSG, IDG Capital, GL Ventures, and 5Y Capital with participation from Gaorong Ventures, Primavera Venture Partners, Boyu Capital, SBP Group, and the state-backed Shanghai Future Industries Fund....See more